Electronic medical record review of de-identified patients who tested positive forCOVID-19 (using a PCR test) at Methodist Dallas Medical Center (MDMC) from June 2020until the date of IRB approval. Data will be collected on de-identified patients thattest positive for COVID-19 (using a PCR test) at MDMC from the date of IRB approval untilDecember 2022. Disclaimer: Any cost associated with the procedures stated herein will bebilled directly to you or to your insurance (as applicable)
Electronic medical record review of de-identified patients who tested positive for
COVID-19 (using a PCR test) at Methodist Dallas Medical Center (MDMC) from June 2020
until the date of IRB approval. Data will be collected on de-identified patients that
test positive for COVID-19 (using a PCR test) at MDMC from the date of IRB approval until
December 2022. Variables include patient baseline characteristics, patient presentation,
imaging and labs. Disclaimer: Any cost associated with the procedures stated herein will
be billed directly to you or to your insurance (as applicable)
Other: Chart review
Chart review
Inclusion Criteria:
- Hospitalized patient
- Adult over 18 years
- Positive COVID-19 PCR Test
Exclusion Criteria:
- None
Methodist Dallas Medical Center
Dallas, Texas, United States
Manavjot Sidhu, MD, Principal Investigator
Methodist Health System